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In the mouse embryo, the aorta-gonad-meso-
nephros (AGM) region is considered to be the sole
location for intraembryonic emergence of hemato-
poietic stem cells (HSCs). Here we report that, in
parallel to the AGM region, the E10.5–E11.5 mouse
head harbors bona fide HSCs, as defined by long-
term, high-level, multilineage reconstitution and
self-renewal capacity in adult recipients, before
HSCs enter the circulation. The presence of hemo-
genesis in the midgestation head is indicated by
the appearance of intravascular cluster cells and
the blood-forming capacity of a sorted endothelial
cell population. In addition, lineage tracing via an
inducible VE-cadherin-Cre transgene demonstrates
the hemogenic capacity of head endothelium. Most
importantly, a spatially restricted lineage labeling
system reveals the physiological contribution of
cerebrovascular endothelium to postnatal HSCs
and multilineage hematopoiesis. We conclude that
the mouse embryonic head is a previously unappre-
ciated site for HSC emergence within the developing
embryo.
INTRODUCTION
Hematopoietic stem cells (HSCs) can continuously produce
hematopoietic cells of all lineages throughout the lifetime of an
individual. Experimentally, they are defined by the competenceCellto engraft into the bone marrow (BM) of lethally irradiated recip-
ients and the ability to rebuild all the components of hematopoi-
etic system via self-renewal and differentiation. Whereas BM
serves as the main niche for supporting HSC activity in postnatal
stage, the early emergence, stepwise maturation, and remark-
able expansion of fetal HSCs occurs in different locations and
is temporally restricted during mouse embryogenesis (Cumano
and Godin, 2007; Dzierzak and Speck, 2008; Mikkola and Orkin,
2006).
The first visible blood cells, the nucleated primitive erythro-
cytes producing embryonic hemoglobin, arise in the mouse
extraembryonic yolk sac (YS) at embryonic day 7.0–7.5 (E7.0–
7.5), concomitant with the developing vasculature (McGrath
and Palis, 2005). Shortly thereafter, the YS yields a cohort of uni-
lineage and multilineage erythromyeloid progenitors that can
migrate into the embryo proper via circulation (Lux et al.,
2008). As the HSCs are positioned at the top of the hematopoi-
etic hierarchy and can ensure life-long production of blood cells,
the questions of when, where, and how the HSCs are generated
duringmammalian embryogenesis are under intensive investiga-
tions but remain highly debated (Yoshimoto et al., 2008). Among
various midgestation embryonic tissues, the cells capable of
long-term, high-level, and multilineage hematopoietic repopula-
tion can first be exclusively detected in the E10.5 (>35 somite
pairs; sp) aorta-gonad-mesonephros (AGM) region (Mu¨ller
et al., 1994). As further revealed by organ or reaggregation
cultures, the HSC potential of the AGM region can be autono-
mously and remarkably augmented via maturation of a large
number of nascent HSC precursors (pre-HSCs) (Cumano et al.,
1996; Medvinsky and Dzierzak, 1996; Taoudi et al., 2008). More-
over, HSCs are detected simultaneously or slightly later in other
major vessels (umbilical arteries and vitelline arteries) or highly
vascularized structures (placenta and YS) at E10.5–E11.0Stem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier Inc. 663
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Dzierzak, 2005; Rhodes et al., 2008). Interestingly, a type of
newborn-repopulating HSC has been identified in both the YS
and the para-aortic splanchnopleura (P-Sp, destined to form
the AGM region) of E9.5 embryos via intraliver transplantation.
Such cells are CD34+c-Kit+ and CD41+, and can further engraft
into the BM of adults, implicating that they are immature precur-
sors of adult-type HSCs (Ferkowicz et al., 2003; Yoder et al.,
1997). Furthermore, using a nonheartbeat Ncx1/ mouse
model, T and B lymphoid potential are observed in the P-Sp,
YS, and placenta of E9.5 embryos, suggesting that the genera-
tion of lymphoid progenitor cells is independent of circulation
(Rhodes et al., 2008). Notably, the placenta contains 15-fold
more HSCs than AGM and YS at E12.5–E13.5 (Gekas et al.,
2005). Unlike the hemogenic sites, the fetal liver cannot form
HSCs de novo but is colonized by external HSCs via circulation
(Zovein et al., 2008).
During the entire course of embryonic hematopoiesis, the
formation of blood cells is closely correlated with vascular devel-
opment. For the mouse embryo proper, vasculogenesis is initi-
ated at E7.3 in the cranial part, and the dorsal aorta becomes
discernable slightly later (Drake and Fleming, 2000). Interest-
ingly, putative angioblasts within the rostral vasculature coex-
press Flk-1 and Scl, the markers of hematopoietic specification
from mesodermal precursors. By analyzing the hemogenic
potential of epiblast tissue at E6.5–E7.7, Kanatsu et al. found
that the anterior head-fold has hemogenic potential if activin or
BMP4 is added (Kanatsu and Nishikawa, 1996). At E9.5, the
head contains a number of erythromyeloid progenitors no less
than the number in the AGM region (Palis et al., 1999). More strik-
ingly, after the AGM and fetal liver are removed, the remnants of
the E11 embryo proper demonstrate robust HSC potential
in vivo, which is not detected in concomitant circulating cells
(Mu¨ller et al., 1994). Intriguingly, prior to circulation, the zebrafish
head is an important site for early embryonic hematopoiesis,
including genesis of macrophages and granulocytes (Bennett
et al., 2001; Herbomel et al., 1999; Le Guyader et al., 2008).
The above direct and indirect clues prompted us to comprehen-
sively analyze the hematopoietic activity in the rostral half of
embryo proper during mouse midgestation.
Here, we report that the mouse E10.5–E11.5 head harbors
authentic HSCs, which demonstrate long-term, efficient, and
multilineage reconstitution and self-renewal capacity in lethally
irradiated adult recipients. Such potential cannot be explained
by later and rare emergence of HSCs in the embryonic circula-
tion. Development of hemogenic endothelium in the head is
further confirmed by morphological, functional, and lineage
tracing strategies. More convincingly, in a unique SP-A-Cre
transgenic mouse model, which is a fully physiological setting,
the cerebrovascular endothelium demonstrates de novo hema-
topoietic potential and contribution to postnatal HSCs.
RESULTS
Erythromyeloid Progenitors in the Mouse Embryonic
Head
In E9.5–E12.5 embryos (Figure 1A, a representative E10.5
embryo), the numbers of colony-forming units in the culture
(CFU-Cs) of the caudal half (CH) or AGM region seemed steady664 Cell Stem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier In(Figure 1B). In contrast, dramatic changes were observed in the
head region. The number of CFU-Cs was increased from E9.5
(131 per tissue), peaked at E11.5 (1,074 per tissue), and then
declined at E12.5 (704 per tissue). The percentage of CFU-GM
and CFU-Mix in the head and CH/AGM appeared to be compa-
rable between E9.5–E11.5 (Figure 1C, and data not shown). The
CFU-Cs in the E10.5–11.0 head were mainly enriched in the
Tie2+ population (Figure 1D).
B and T Lymphoid Potential in the Mouse Embryonic
Head
Lymphoid potential is thought to be an important indicator of
definitive hematopoiesis. Here, the OP9 and OP9-DL1 cells
were used to induce B and T lymphocytes, respectively. After
being cocultured with the OP9 cells for 8–9 days, the Tie2+ cells
from E9.5 heads were significantly expanded (Figure 1E), to an
average of 4.1 3 105 cells per head region (from three indepen-
dent experiments). Flow cytometry detected CD19+ (44.6%–
68.6%) populations (Figure 1F). For one embryo equivalent
(ee), the Tie2+ head cells gave rise to 2.34 3 105 CD19+ B cells,
slightly lower than the CH ones (Figure 1G). For T lymphocyte
differentiation, three or four passages on fresh OP9-DL1 feeders
were required over 3–4 weeks. From day 13 onward, the head/
OP9-DL1 cocultures generated a CD25+CD44 population,
with a stepwise increase from 8.9% to 24.9%, indicating an
early commitment to T cell lineage (Figure 1H). At day 26, the
CD4+CD8+ and CD3+TCRb+ populations reached up to 7.6%
and 7.8%, respectively. That is, 1 ee of head could yield
1.13 3 109 CD4+CD8+ and 1.16 3 109 CD3+TCRb+ cells in the
coculture. Similarly, the Tie2+ cells from E9.5 CH gave rise to
1.70 3 109 CD4+CD8+ and 2.22 3 109 CD3+TCRb+ cells
(Figure 1H).
Development of Adult-Repopulating HSCs in the Mouse
Embryonic Head
Long-term transplantation is widely accepted as the most strin-
gent and reliable assay for HSC activity. Previous literatures indi-
cate that the adult-repopulating HSCs are rare in the mouse
E10.5 conceptus (Gekas et al., 2005; Kumaravelu et al., 2002;
Mu¨ller et al., 1994). Mu¨ller et al. revealed that the first adult-
reconstituting HSC arose exclusively in the AGM region of
E10.5 conceptus (34–41 sp), but its engraftment efficiency was
low as only 3 out of 96 recipients in total were repopulated
(Mu¨ller et al., 1994). Since the E9.5–E11.5 head region demon-
strated robust multipotent lymphomyeloid potential in vitro, we
wondered whether adult-repopulating HSCs developed concur-
rently in this site. Here, to improve the efficacy, we used more
cells (1.7–2.5 ee per recipient) and a higher radiation dose
rate (2.3 Gy per minute). The total cell numbers for transplanta-
tion at indicated time points are shown in Table S1 (available
online). As shown in Table 1 and Figure 2A, none of the
recipients transplanted with 1 ee of E10.5 (36–41 sp) AGM was
repopulated with >10% chimerism after 16 weeks (n = 13, four
independent experiments). Three recipients displayed <5.0%
chimerism after 4 weeks, but the positive signals disappeared
when retested 16 weeks posttransplantation (data not shown).
In contrast, with 1.7–2.5 ee injection, 14–15 out of 39–40 recipi-
ents (13 independent experiments) were repopulated, with an
average short-term chimerism of 27.5% ± 14.6% (>4 weeks)c.
Figure 1. Lymphomyeloid Potential in the Mouse Embryonic Head
(A) Schematic dissection of head and AGM region from an E10.5 embryo.
(B) Numbers of CFU-Cs in E9.5–E12.5 head and caudal half (CH, E9.5) or AGM region (E10.5–E12.5). Data are expressed asmeans ± SEM, and are collected from
three (E9.5–E11.5) or two (E12.5) independent experiments.
(C) Percentage of CFU-GM and CFU-Mix in total CFU-Cs of head and AGM region at E10.5.
(D) Colony numbers per 105 cells were calculated in Tie2+ and Tie2 populations of E10.5–E11.0 head. Data are means ± SEM.
(E) Morphology of E9.5 head Tie2+ cells after 8–9 days of B lymphocyte induction on OP9, showing significant expansion of semiadherent population.
(F) Expression of CD19 in the E9.5 head cultures analyzed by flow cytometry.
(G) The absolute numbers of CD19+ cells per E9.5 tissue. Data are means ± SEM from three independent experiments.
(H) T lymphoid potential in E9.5 head and CH. At indicated time points, expression of CD44/CD25, CD4/CD8, and CD3/TCRb in head (left two columns) and CH
(right two columns) cocultured with OP9-DL1 were analyzed by flow cytometry.
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HSC Development in Mouse Embryonic Headand long-term chimerism of 46.6% ± 22.4% (>16 weeks). In
parallel, transplantation with E10.5 head cells led to successful
reconstitution in 4–5 out of 40 recipients, with an average
short-term chimerism of 27.3% ± 10.3% and long-term chime-Cellrism of 57.2% ± 22.9%. Two successful recipients received
donor cells from the heads of <40 sp (1 of 37–38 sp and 1 of
38–39 sp heads, from two independent experiments). However,
transplantation with 1.7–2.5 ee cells from E10.5 embryonicStem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier Inc. 665
Table 1. The Emergence of Adult-Repopulating HSCs in the Mouse Embryonic Head and AGM Region
Time Posttransplantation >4 Weeks >16 Weeks
Stage Organ eea Exp (n) Reb/Total Chimerism (%) Re/Total Chimerism (%)
E10.5 (36–41 spc) head 1 4 0/11 NAd 0/9 NA
1.7–2.5 13 4/40 27.3 ± 10.3 5/40 57.2 ± 22.9
AGM 1 4 0/13 NA 0/11 NA
1.7–2.5 13 14/40 27.5 ± 14.6 15/39 46.6 ± 22.4
blood 1 4 0/5 NA 0/5 NA
1.7–2.5 11 0/29 NA 0/27 NA
E11.5 (42–50 sp) head 0.3 4 1/16 48.0 2/23 19.5, 56.4
1 6 10/18 27.8 ± 10.5 8/20 54.6 ± 23.8
AGM 0.3 3 0/16 NA 0/16 NA
1 5 9/15 32.8 ± 14.7 9/15 47.9 ± 20.9
blood 0.3 1 0/5 NA 0/5 NA
1 5 3/15 36.5 ± 6.5 3/15 48.0 ± 19.3
E12.5 head 0.5 3 12/21 39.5 ± 17.5 13/21 49.3 ± 19.0
AGM 0.5 3 6/11 34.7 ± 14.2 5/11 50.1 ± 22.2
aee, embryo equivalents.
bRe, repopulated.
csp, somite pairs.
dNA, not available.
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independent experiments), consistent with previous studies
(Gekas et al., 2005; Mu¨ller et al., 1994). At E11.5, transplantation
of 1 ee of head cells (42–50 sp) resulted in 40% of recipients
(8/20) being efficiently repopulated, with an average long-term
chimerism of 54.6% ± 23.8%. The efficiency was approaching
that of the AGM region (60%, 9/15). Notably, two recipients
could be repopulated with 0.3 ee of E11.5 head cells. At this
time point, the embryonic circulating cells began to display
reconstitution capacity (3 repopulated out of 15 recipients). Of
note, repopulation was only detected in the recipients trans-
planted with late E11.5 circulating cells (from pooled 44–47 sp
or 47–50 sp embryos). The inability of early E11.5 (<45 sp)
embryonic circulating cells to reconstitute the adult hosts at
high levels has been documented in several reports (Gekas
et al., 2005; Mu¨ller et al., 1994). Furthermore, with infusion of
0.5 ee of E12.5 head cells, 13 out of 21 recipients could be effi-
ciently repopulated, resembling that of the AGM region (5/11).
Bona fide HSCs are functionally identified by two features:
multilineage reconstitution and self-renewal ability. We analyzed
multilineage repopulation in hematopoietic organs from recipi-
ents of head or AGM-derived cells (Figures 2B–2E; Figures
S1A–S1D). The presence of E10.5 head- (38–39 sp) derived
GFP+ myeloid (Gr-1+ or Mac-1+), B lymphoid (B220+), and T
lymphoid (CD3+) cells was detected in the peripheral blood
of repopulated recipient 6 months after transplantation (Fig-
ure 2B). Likewise, in the BM, thymus, and spleen of the same
recipient, efficient multilineage engraftment was observed
(Figures 2C–2E). Furthermore, self-renewal capacity was inves-
tigated by secondary transplantation of 3 3 106 BM cells from
primary recipients that had been successfully repopulated with
E10.5 head- or AGM-derived cells (Figure 2F). For instance,
the BM cells from the recipient repopulated by head cells of
38–39 sp could efficiently engraft into the secondary hosts (H1666 Cell Stem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier Inin Figure 2F), as revealed by multilineage chimerism in the
peripheral blood 6 months after transplantation (Figure S1E).
As expected, BM cells from E10.5 AGM-repopulated recipients
(all donors of 36–41 sp) demonstrated a similar self-renewing
capacity (Figure 2F and Figure S1E).
Subsequently, we analyzed the immunophenotype of head
HSCs. Similar to CFU-Cs in vitro, transplantation of Tie2+ rather
than Tie2 population from E12.5 head led to reconstitution in 4
out of 12 recipients, similar to the AGM region (5/12, Figure 2G).
Reportedly, HSCs in the mouse AGM, YS, and placenta reside
in the CD34+c-Kit+ population (Gekas et al., 2005; Sa´nchez
et al., 1996; Yoder et al., 1997). Likewise, the CD34+c-Kit+ pop-
ulation in the E12.5 head, constituting 0.2%–0.3% of collage-
nase-digested cells, could efficiently repopulate irradiated adult
recipients (3/13) over 6 months (Figure S1F, two independent
experiments).
Expression of Hematopoietic Genes in the Mouse
Embryonic Head
Combinations of c-Kit with CD34, CD41, or CD45 were used to
roughly calculate the number of hematopoietic precursors. The
frequencies of CD34+c-Kit+, CD41+c-Kit+, and CD45+c-Kit+ cells
were comparable between the head and AGM region of E10.5
embryos (Figure 3A). Quantitatively, 1 ee of E10.5 head con-
tained 6.8 3 103 CD34+c-Kit+, 4.0 3 103 CD41+c-Kit+, and
3.8 3 103 CD45+c-Kit+ cells on average (Figure 3B, three inde-
pendent experiments). The double positive populations were
also evident in the E9.5 and E11.5 head region (Figures S2A
and S2B).
Next, real-time PCR was used to quantify the mRNA levels of
hematopoietic/endothelial-related molecules in the head and
AGM region. In particular, it is reported that Runx1 is expressed
in all of the adult-repopulating HSCs of midgestation mouse
embryos (North et al., 2002), and the proximal P2 promoterc.
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promoter, in the endothelium-hematopoietic cell transition (Bee
et al., 2010; Chen et al., 2009; Sroczynska et al., 2009). As shown
in Figure 3C, at E10.5, the transcription levels of Scl, P2-Runx1,
and GATA-2 in the head were 1.5-, 1.6-, and 2.3-fold relative,
respectively, to that in the AGM region of littermates (three or
four independent experiments). The expression levels of endo-
thelial markers were comparable. Furthermore, the expression
levels of three transcriptional factors were analyzed in specific
subpopulations (Tie2+ or CD31+c-Kit+) that enriched hematopoi-
etic potential in vitro and in vivo. Compared with E10.5, a signif-
icant decrease of P2-Runx1 transcription was observed in the
CD31+c-Kit+ subsets of E11.5 embryos (Figure S2C), implying
the downregulation of endothelial-hematopoietic transition. In
contrast, a doubling of GATA-2 transcription at E11.5 might indi-
cate expansion of hematopoietic stem progenitor cells (Fig-
ure S2C). Comparable expression of P2-Runx1 between head
and AGM was observed in either Tie2+ or CD31+c-Kit+ popula-
tion (Figures 3D and 3E). These data suggested a cellular and
molecular phenotype matching the hematopoietic potential of
the head.
Hematopoietic Potential and Phenotype in the Mouse
E8.25 Head
A previous report has documented the hematopoietic potential
of gastrulating head region in optimized conditions (Kanatsu
and Nishikawa, 1996). Here, the head and CH were carefully iso-
lated from the precirculation embryo proper (E8.25, 1–6 sp) (Fig-
ure S2D), digested into single-cell suspension, and transferred to
OP9 stromal cells in accordance with recent reports (Yoshimoto
et al., 2011). After 3 days, the clones composed of semiadherent
round cells formed (Figure S2E), some of which underwent
significant expansion within the next 5–7 days. As a result, the
CH cells yielded a total of 83 clones in 11 experiments, and the
head, 12 clones in 5 experiments. Flow cytometry analysis
showed the presence of CD19+ cells in four experiments of the
CH cocultures, a rate more frequent than that of the head cocul-
tures (one experiment, Figure S2F). Notably, under the same
conditions, the E8.25 YS was also capable of generating
CD19+ B lymphocytes (data not shown). Subsequently, the cells
coexpressing CD41 and c-Kit, which represent definitive hema-
topoietic progenitors (Ferkowicz et al., 2003; Mikkola et al.,
2003), were analyzed by flowcytometry. As shown in Figure S2G,
the head region andCH had 0.14%–0.44%and 0.11%–0.76%of
CD41+c-Kit+ cells, respectively. At E8.5 (8–12 sp), the frequency
was significantly increased in the head (1.24% on average) and
CH (1.37% on average) (Figure S2G, three independent experi-
ments). It was interesting to note that a small population of
CD34+c-Kit+ was present in both E8.25 head and CH (Fig-
ure S2H). In comparison, expression of CD144, Sca-1, and
CD45 was very limited in the c-Kit+ population (Figure S2H).
Real-time PCR analysis showed comparable expression of Scl,
Flk-1, and P2-Runx1 in the E8.25 head, compared with CH
(Figure S2I).
Hemogenic Potential in the Mouse Embryonic Head
Given the obvious hematopoietic capacity of the embryonic
head, we aimed to determine whether the head could generate
blood cells de novo via an endothelial intermediate, which hasCellbeen observed in the known hemogenic sites, such as AGM,
YS, and placenta. To address the issue, a set of experiments
were conducted.
In the AGM region, intra-aortic cluster cells expressing endo-
thelial markers are thought to grow out from the putative hemo-
genic endothelium, which is visualized initially at E9.5 and maxi-
mally at E10.5. Such cluster cells coincide with a distinguished
CD31+c-Kithigh subset in flow cytometry (Yokomizo and Dzier-
zak, 2010). As shown in Figure 4A, the close association of the
CD31+ cluster cells with the arterial endothelium was observed
in the E10.5 head region. More importantly, as shown in Fig-
ure 4B, the E10.5 head had a unique CD31+c-Kithigh population
(0.063%–0.113%, n = 3), resembling the AGM region (0.088%–
0.157%, n = 3).
Next, to determine the existence of functional hemogenic
endothelium, the assumptive endothelial cells, defined as
CD31+CD41CD45Ter119 (Bee et al., 2010), in the E10.0
(31–36 sp) head were sorted by FACS and plated on the OP9
stromal cells (Figure 4C). After 2–3 days of culture, typical hemo-
genic clones appeared (Figure 4D), similar to those from AGM
region. After 7–9 days, a considerable number of CD45+ hema-
topoietic cells and CD19+ B lymphocytes were detected
(Figure 4E).
Recently, an in vitro noninvasive endothelial fate tracing
strategy has been proven powerful and sensitive in distinguish-
ing hemogenic from nonhemogenic organs (Zovein et al.,
2008). As depicted in Figure 4F, the tamoxifen-inducible VE-cad-
herin-Cre line (Zovein et al., 2008) was crossed to the ROSA-
tdTOMATO reporter line (Madisen et al., 2010). Then, the Tie2+
cells from head, AGM region, and circulating blood of the
E11.0 double transgenic embryos were pulsed by 4-OHT for
24 hr and cocultured with OP9 stromal cells for an additional
4 days. Cre recombinase-induced expression of tdTOMATO in
endothelial structures and hematopoietic clusters could be
directly observed under microscope. The tdTOMATO+CD45
endothelial tubules were found in the groups of both head and
AGM region, but not circulation (Figure 4G). As expected,
in vitro 4-OHT induction did not label hematopoietic clusters
generated from circulating cells (Figure 4H), consistent with
previous reports (Zovein et al., 2008). In contrast, several hema-
topoietic clusters derived from the head became tdTOMATO+
and were positive for CD45, resembling those from the AGM
region (Figure 4H). Flow cytometry further confirmed the pres-
ence of CD45+ hematopoietic cells in tdTOMATO+ population
of both the head and AGM cultures and the lack of tdTOMATO+
population in the circulating blood cultures (Figure 4I). These
data collectively verified that the embryonic head had hemo-
genic potential.
Physiological Contribution of Cerebrovascular-Specific
Endothelial Cells to Embryonic and Postnatal
Hematopoietic System
Recently, we developed a unique SP-A-Cre transgenic mouse
line in which Cre activity in endothelial cells is restricted to the
brain vasculature from E11.5 (Li et al., 2011; Meng et al., 2007).
Conceivably, this model is optimal for tracing the hematopoietic
fate of cerebrovascular endothelial cells. First, LacZ staining was
performed in E12.5 SP-A-Cre;ROSA-LacZ double transgenic
embryos. No LacZ+ cells were detected in the aortic endotheliumStem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier Inc. 667
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head sections showed that in some of the morphologically
defined arterioles and arteries, blue-stained LacZ+ blood cells
were detected and some appeared to be ‘‘budding’’ from the
endothelial layer (Figure 5A). In contrast, no positive signal was
observed in blood cells in the lumen of typical veins (Figure 5A).
These data highly suggested an in situ hematopoietic activity in
the cerebrovasculature.
Next, certain hematopoietic and endothelial populations were
quantified by flow cytometry using fluorescein di-b-D-galacto-
pyranoside (FDG) as the substrate for b-galactosidase (b-gal).
The Tie2-Cre transgenic mice were examined in parallel as
a positive control. The Tie2-Cre-mediated ablation occurs in
all endothelial/hematopoietic cells from E8.5 (Lan et al.,
2007), which is much earlier than SP-A-Cre expression, and
encompasses the entire period of hemogenic activity in the
endothelium. We demonstrated that in the head of E11.5 Tie2-
Cre;ROSA-LacZ double transgenic mice, 48.1% of the CD31+
population and 45.4% of the CD45+ population were positive
for b-gal expression. Moreover, 10.5% of the CD31+ population
and 4.6% of the CD45+ population contained the recombined
allele in the head of E13.5 SP-A-Cre;ROSA-LacZ double trans-
genic mice (Figure 5B).
We then turned to an in vitro coculture system and found that
after coculture with OP9, the Cre-mediated recombination in
endothelial/hematopoietic cells derived from E12.5 head was
greater than that in vivo. Tie2-Cre-mediated ablation was evi-
denced by a remarkable shift of the cell population peak to
FDG+. In SP-A-Cre;ROSA-LacZ double transgenic mice, 20%
of the CD31+ population and 8.4% of the CD45+ population
were positive for FDG. When gated on the CD45+c-Kit+ popula-
tion, representative of hematopoietic progenitors, 12.3% of cells
were FDG+. Notably, when gated on the B220+CD19+ lympho-
cyte population, the hallmark of definitive hematopoiesis,
27.6% of cells were positive for expression of b-gal (Figure 5C).
In contrast, FDG+CD45+ cells were not detected in the parallel
culture of AGM cells from SP-A-Cre;ROSA-LacZ double trans-
genic mice (Figure S3B).
Finally, the physiological contribution of SP-A-expressing cells
to the postnatal hematopoietic system was investigated. In the
BM of 4-week-old SP-A-Cre;ROSA-LacZ double transgenic
mice, approximately 4.2%–4.5% of the enriched HSC popula-
tion (CD150+CD48LinSca-1+c-Kit+, CD150+CD48LSK) (Kiel
et al., 2005) exhibited b-gal labeling (Figure 6A). Multilineage
contribution was also detected in the BM (Figure S4). In a simpler
way, we used the ROSA-EYFP reporter mice to bypass the stepFigure 2. Early Emergence of Adult-Repopulating HSCs in the Mouse
(A) Repopulating potential of mouse embryonic head and AGM region at E10.5 (le
CD45+ cells in peripheral blood of individual recipients over 4 months posttransp
topoietic tissues and circulating blood.
(B–E) Multilineage repopulation of E10.5 head cells after transplantation. The dono
Gr-1), B lymphoid (B220), and T lymphoid (CD3, CD4, and CD8) cells of peripher
6 months posttransplantation. The recipient was injected with 2 ee of E10.5 hea
(F) Repopulating potential of BM cells derived from repopulated primary recipient
region (A1–A3: 36–41 sp). Symbols represent the donor chimerism of CD45+ ce
transplantation. Identical symbols indicate each donor and related secondary re
(G) Immunophenotype of E12.5 head HSCs. Repopulating potential of Tie2+ and
independent experiments). Symbols represent the donor chimerism of CD45+ cell
See also Figure S1.
Cellof FDG labeling (Srinivas et al., 2001). In the 4- to 6-week old
SP-A-Cre;ROSA-EYFP double transgenic mice, EYFP+ cells
constituted 5.9%–7.7% of the BM CD150+CD48LSK popula-
tion (Figures 6B and 6E). Moreover, different levels of contribu-
tion were detected in the erythroid (Ter119+, 2.3%–5.8%),
myeloid (Gr-1+/Mac-1+, 3.1%–7.6%), B lymphoid (B220+,
1.8%–7.7%), and T lymphoid (CD3+, 2.8%–9.6%) cells of BM
(Figures 6C and 6E). A similar pattern was present in the periph-
eral blood (Figures 6D and 6E).
DISCUSSION
In a conventional view, early intraembryonic hematopoiesis
occurs exclusively in the caudal AGM region. Our findings
provide evidence that the area of hematopoietic potential in
the embryo proper may be larger than previously thought. As
the earliest intraembryonic vasculogenesis occurs in the head
region, our studies further emphasize the well-known develop-
mental intimacy between vasculature and blood ontogeny.
In this study, the intraembryonic distribution of adult-type
HSCs in midgestation mouse embryos was reevaluated using
a modified irradiation strategy. Theoretically, an increased
dose rate of irradiation can be more effective at depleting
HSCs in the recipients and may induce greater production of
various hematopoietic growth factors and cytokines. All these
features can enhance donor cell engraftment. Unexpectedly,
the early emergence of standard adult-repopulating HSCs was
revealed in the E10.5–E12.5 head region. This finding may
convincingly explain why E11 mouse embryo proper without
AGM and fetal liver could successfully repopulate irradiated
recipients (Mu¨ller et al., 1994). Intriguingly, at E10.5–E11.5, the
donor chimerism by transplantation of head cells was very
similar to that of AGM region, much higher than the E11.5–
E12.5 fetal liver (Gekas et al., 2005). Nevertheless, themagnitude
of HSC potential in the head, AGM, and YS is not as remarkable
as that of the placenta, which harbors a large pool of approxi-
mately 50 adult-type HSCs at E12.5 (Gekas et al., 2005). More-
over, the head HSCs had a CD34+c-Kit+ and Tie2+ surface
phenotype, similar to HSCs from AGM region, placenta, and
YS. In contrast, the E12.5 fetal liver harbors both CD34+c-Kit+
and CD34c-Kit+ HSCs (Gekas et al., 2005). In terms of HSC
potential and phenotype, the head is more similar to the AGM
region than the fetal liver.
Importantly, the head HSCs emerged before they could be
detected in the embryonic circulation. Although considered to
be responsible for HSC migration and exchange among distinctEmbryonic Head
ft), E11.5 (middle), and E12.5 (right). Symbols represent the donor chimerism of
lantation. Injected dosage is expressed as embryo equivalents (ee) of hema-
r contribution is revealed by presence of GFP+ cells in the myeloid (Mac-1 and
al blood (B), BM (C), spleen (D), and thymus (E) of a representative recipient at
d cells (38–39 sp).
s transplanted with E10.5 head (H1: 38–39 sp; H2 and H3: 36–41 sp) and AGM
lls in peripheral blood of individual secondary recipients over 6 months post-
cipients.
Tie2 cells derived from E12.5 mouse embryonic head and AGM region (two
s in peripheral blood of individual recipients over 4 months posttransplantation.
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Figure 3. Cellular and Molecular Characterization of Hematopoietic Phenotype in the Mouse Embryonic Head
(A) Coexpression of c-Kit with CD34, CD41, or CD45was analyzed in 7-AAD live cells of E10.5 head and AGM region by flow cytometry. Representative plots are
shown.
(B) Quantification of CD34+c-Kit+, CD41+c-Kit+, and CD45+c-Kit+ cells in E10.5 head and AGM region. Data are means ± SEM from three independent exper-
iments.
(C–E) Expression of hematopoietic-related transcriptional factors or/and endothelial molecules in the tissues (C), Tie2+ cells (D), or CD31+c-Kit+ cells (E) of E10.5–
E11.5 head relative to AGM region analyzed by real-time PCR. Data are means ± SEM.
See also Figure S2.
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HSC Development in Mouse Embryonic Headanatomical sites, a precise timing of initial presence of HSCs in
circulation has not been consensually validated. Here, we found
that circulating cells in late E11.5 embryos were capable of
reconstituting adult primary recipients. Surprisingly, the BM cells
from two repopulated recipients failed to establish >5% chime-
rism in secondary recipients (data not shown). Previously, no670 Cell Stem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier Inor low-level chimerism (<5%) has been observed in the periph-
eral blood of recipients infused with E11.5 circulating cells
(Gekas et al., 2005; Mu¨ller et al., 1994; Yokomizo and Dzierzak,
2010). In contrast, Kumaravelu et al. conclude that E11.5 circu-
lation contains HSCs; however, some key data, particularly
those of the secondary transplantation, were not fully displayedc.
Figure 4. Hemogenic Potential in the Mouse Embryonic Head
(A) CD31 immunostaining (brown) of E10.5 head sections. Blue arrowheads indicate typical intraluminal cluster cells expressing CD31 ‘‘budding’’ from the
endothelial layer of the vessel wall.
(B) Flow cytometry analysis reveals CD31+c-Kithigh cluster-like population in the 7-AAD live cells of head and AGM region of E10.5 embryos.
(C–E) Hemogenic potential of immunophenotypically defined endothelial cells in the head. Live endothelial cells (7-AADCD31+CD41CD45Ter119) of E10.0
(31–36 sp) head were sorted by flow cytometry (C). Morphology of typical hemogenic clones after 2–3 days of OP9 coculture (D). Flow cytometry analysis
detected CD45+ hematopoietic cells and CD19+ B lymphocytes after 7–9 days of coculture (E).
(F) Schematic illustration of the experimental protocol to explore the hemogenic potential in the head by using an inducible VE-cadherin-Cre;ROSA-tdTOMATO
double transgenic mouse model.
(G and H) Fluorescence microscope examination of CD45 immunostained cultures, showing the VE-cadherin-Cre recombinase-induced expression of tdTO-
MATO (red) in endothelial tubules in the cultures of head and AGM region (G), and tdTOMATO+ (red) CD45+ (green) hematopoietic cells in the cultures of head and
AGM region, contrasting with only tdTOMATOCD45+ cells in the culture of circulating blood (H).
(I) Flow cytometry analysis showsCD45 expression in gated tdTOMATO+ populations fromboth head and AGMcultures and lack of tdTOMATO+ population in the
circulating blood culture.
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Figure 5. Hematopoietic Potential of Cerebrovascular Endothelial Cells in the Mouse Embryo
(A) Head sections of whole-mount LacZ-stained E12.5 SP-A-Cre;ROSA-LacZ double transgenic embryos, showing b-gal-labeled endothelial and blood cells.
Red arrowheads show vessels with b-gal+ blood cells inside and some closely associated with the endothelial layer. Black arrowhead shows a vein without
internal b-gal+ blood cells.
(B and C) FACS analysis of b-gal activity in the subpopulations of freshly prepared head cells from E11.5 Tie2-Cre;ROSA-LacZ (upper) and E13.5 SP-A-
Cre;ROSA-LacZ (lower) double transgenic embryos (B), and of the cultured Tie2+ head cells from E12.5 Tie2-Cre;ROSA-LacZ (upper) and E12.5 SP-A-
Cre;ROSA-LacZ (lower) double transgenic embryos (C). ROSA-LacZ littermates without the Cre transgene (Cre) serve as negative controls (red lines). The Cre-
mediated recombination is indicated by a shift of the cell population to FDG+.
See also Figure S3.
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HSC Development in Mouse Embryonic Headin the literature (Kumaravelu et al., 2002). The question of
whether authentic HSCs appear in E11.5 embryonic circulation
needs future examination.
We further delineated that, similar to the dorsal aorta, the
embryonic head contained a specific type of endothelium that
was hemogenic and harbored de novo blood-forming capacity.
Here, three approaches were employed based on an in vitro672 Cell Stem Cell 11, 663–675, November 2, 2012 ª2012 Elsevier InOP9 coculture system to reflect the hemogenic potential of
head endothelium, two of which involved Cre-mediated fate
tracing of temporally or spatially confined endothelial cells. The
advantage of the inducible VE-cadherin-Cre line is that it can
delicately recognize the true hemogenic sites via separate organ
cultures (Zovein et al., 2008). In contrast to the AGM and the
head region, hemogenic potential was absent in circulation,c.
Figure 6. Contribution of Cerebrovascular Endothelial Cells to Post-
natal Hematopoietic System
(A) Representative FACS analysis of b-gal activity in the putative HSCs
(CD150+CD48LSK) of 7-AAD live BM cells from a 4-week-old SP-A-
Cre;ROSA-LacZ double transgenic mouse. The ROSA-LacZ littermate
without the Cre transgene (Cre) serves as negative control (red lines). The
Cre-mediated recombination is indicated by the shift of the cell population to
FDG+.
(B–D) Representative FACS analysis of EYFP fluorescence in CD150+
CD48LSK of BM cells (B) and in multilineages of BM (C) and peripheral blood
(D) from a 6-week-old SP-A-Cre;ROSA-EYFP double transgenic mouse. The
ROSA-EYFP littermate without the Cre transgene serves as negative control
(red lines).
(E) Percentage of EYFP+ cells in the BM and peripheral blood of 4- to
6-week-old SP-A-Cre;ROSA-EYFP double transgenic mice. M: myeloid
lineage, Gr-1+/Mac-1+; E: erythroid lineage, Ter119+; B: B lymphoid lineage,
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Cellsuggesting that the considerable circulation-derived hematopoi-
esis on OP9 must be a result of hematopoietic expansion rather
than hemogenesis from the endothelium. Therefore, the head is
now identified as a member of the group of specific vascular
beds for HSC emergence. In the near future, the technology of
real-time imaging of the AGM region should be refined and
used to directly witness de novo generation of phenotypically
and even functionally defined hematopoietic stem progenitor
cells from the cerebrovasculature (Boisset et al., 2011).
Among the strategies used to define the spatial origin of adult
HSCs, lineage tracing via specific Cre transgenes has provided
the most physiological evidence (Samokhvalov et al., 2007;
Yoshimoto et al., 2008; Zovein et al., 2008). The SP-A-Cre trans-
genic mouse is a valuable and unique tool to investigate hema-
topoietic potential exclusively in the head. Importantly, the
observation that hematopoietic activity in SP-A-Cre-expressing
cells and their progeny was detected only in the head and not
in other tissues of midgestation embryos strongly indicated the
in situ emergence of blood cells. As documented, via a putative
endothelial-hematopoietic transition, all HSCs became CD45+ in
the E11.5 AGM region (Kumaravelu et al., 2002; North et al.,
2002), the time when SP-A-Cre began to be expressed in the
embryonic head. It is conceivable that the hemogenic activity
of endothelium after E11.5 may be a remnant. Notably, the
distinct endothelial populations derived fromSP-A-Cre-express-
ing cells constituted only 10%–20%of CD31+ endothelial cells in
the developing embryonic head. Therefore, the contribution of
the cerebrovasculature to postnatal blood cells may be underes-
timated in this system. Even so, a clear contribution of these
endothelial cells to all the mature lineages and putative HSCs
was detected in postnatal BM and peripheral blood. Therefore,
this model enables us to discern, isolate, and analyze the post-
natal blood cells of a precise embryonic origin.
Importantly, the emergence of hematopoietic precursor cells
during head vasculature development may have certain clinical
implications. For example, hemangioblastoma, which is a type
of central nervous system tumor, is highly vascularized and
occurs sporadically or as a component of von Hippel-Lindau
(VHL) disease (an autosomal dominantly inherited disorder).
The cytological origin of hemangioblastoma is not clear. Surpris-
ingly, the neoplastic cells express Brachyury, Scl, Flk-1, Tie2,
and GATA-1 and are able to form blood-island-like structures
with hematopoietic potential (Gla¨sker et al., 2006; Vortmeyer
et al., 2003). Given the in situ hematopoietic potential of cerebral
endothelial cells described here, whether hemangioblastoma
originates from developmentally arrested precursors in the
embryonic head deserves further investigations.
EXPERIMENTAL PROCEDURES
Animals
Mice were kept at the Animal Center of the Academy of Military Medical
Sciences according to institutional guidelines.GFP-transgenic mice, inducible
VE-cadherin-Cre transgenic mice, SP-A-Cre transgenic mice, Tie2-Cre trans-
genic mice, ROSA-LacZ reporter mice, ROSA-tdTOMATO reporter mice, and
ROSA-EYFP reporter mice have been reported elsewhere (Lan et al., 2007;B220+; T: T lymphoid lineage, CD3+; HSC: CD150+CD48LSK. Identical
symbols indicate related data from an individual (n = 4, from four litters).
See also Figure S4.
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HSC Development in Mouse Embryonic HeadLi et al., 2011; Madisen et al., 2010; Meng et al., 2007; Soriano, 1999; Srinivas
et al., 2001; Tan et al., 2005; Zovein et al., 2008).
OP9 Cocultures
To determine hematopoietic or hemogenic potential, MACS-sorted Tie2+ cells
or FACS-sorted CD31+CD41CD45Ter119 endothelial cells were cultured
on mouse OP9 stromal cells and supplemented with hematopoietic cytokines
(50 ng/ml SCF, 10 ng/ml IL3, 10 ng/ml FL, 10 ng/ml IL-7, and 3 U/ml Epo) or
angiogenic cytokine (100 ng/ml VEGF). For inducible VE-cadherin-Cre;R-
OSA-tdTOMATO embryos, the Tie2+ cells from head, AGM, and circulating
blood were initially treated with 10 mM of 4-OHT (Sigma). After being cultured
for 5–10 days, cells were harvested by mechanical pipetting (hematopoietic
cells) or digesting (endothelial cells) for flow cytometry analysis.
Transplantation Assay
Male GFP-transgenic mice on a C57BL/6 background and female C57BL/6
mice were used to obtain GFP+ embryos. With this strategy, contamination
by maternal cells could be avoided. Female C57BL/6 mice were exposed to
a split dose of 9 Gy g-irradiation (60Co) and injected via tail vein with GFP-
transgenic cells from different tissues or embryonic blood. Simultaneous injec-
tion of 2 3 104 nucleated BM cells of C57BL/6 mice was used to promote
short-term survival. Peripheral blood of the recipients was collected at the indi-
cated time points. Greater than 10% GFP+ cells as determined by FACS was
considered successful reconstitution. A total of 3 3 106 cells from the BM of
reconstituted mice >4–6 months posttransplantation were injected into
secondary recipients to examine self-renewal potential.
Flow Cytometry
Surface markers on enzymatically treated embryonic tissues, lymphocyte
differentiation in vitro, and hematopoietic reconstitution in vivo were analyzed
by flow cytometer FACS Calibur or Aria 2 (BD Biosciences). 7-amino-actino-
mycin D (7-AAD) was used to exclude dead cells. Data were analyzed with
FlowJo software (Tree Star Inc., Ashland, OR). Flow cytometric measurement
of b-gal activity was performed by using FDG (Sigma) in accordance with the
manufacturer’s instructions. Cells loaded with FDG were further stained with
other antibodies using standard procedures.
Statistical Methods
Data were evaluated using a Student’s two-tail t test. p < 0.05 was considered
to be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes four figures, one table, and
Supplemental Experimental Procedures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stem.2012.07.004.
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